Skip navigationEnd of navigation
News
NewsEventsFunding Opportunities

September 13, 2021

ODP Seeking Nominations for 2022 Early Stage Investigator Lecture

The Office of Disease Prevention (ODP) is seeking nominations for its 2022 Early-Stage Investigator Lecture. The award is made annually to early-career scientists who have made significant research contributions in disease prevention but who have not…

September 09, 2021

CASCADE Funding Opportunities

The National Cancer Institute (NCI) has released three notices of intent to publish Funding Opportunity Announcements (FOAs) that will invite applications for a new initiative, the HIV/Cervical Cancer Prevention CASCADE Clinical Trials Network. The…

June 23, 2021

I-SCORE 2021 Meeting Recap

Thank you to all the meeting organizers, presenters, moderators and participants who attended the 2021 I-SCORE Meeting on April 29th and 30th! Despite a change to a virtual format again, over 140 people attended from all over the world. The meeting…

November 18, 2020

First CP-CTNet Participant Enrolled

The University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) has enrolled the first participant onto a CP-CTNet trial, An Extended Follow-up Study of the HPV Vaccine Delayed Booster Trial (UAZ20-01-02). This is a follow-up study…

May 13, 2020

Virtual Translational Research Conference

The Translational Advances in Cancer Prevention Agent Development Meeting will be held virtually on August 27 and 28, 2020. Meeting Objectives: The main goals of this meeting are to: 1) Foster the exchange of ideas and potentially new collaborative…

April 17, 2020

April 2020 I-SCORE Meeting Recap

Thank you to all the presenters and participants who attended the April 2020 I-SCORE Meeting! Despite a change to a virtual format, over 120 people attended. The meeting provided a great opportunity for information-sharing and collaboration between…

March 19, 2020

Guidance for COVID-19 from DCP

Due to concerns regarding the spread of COVID-19 and the impact it is having on hospitals, clinics, physician offices, and clinical trial participants’ ability to travel, the NCI, DCP is providing clarification on measures to address some of the…

Learn more about CP-CTNet on the National Cancer Institute website

This project is supported by the National Cancer Institute (NCI) of the National Institutes of Health under award number U24CA242637. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.


Copyright © 2021, Frontier Science and Technology Research Foundation, Inc. All rights reserved.

Privacy and Terms of Use